Description
Developer of biotherapeutic products for the treatment of lysosomal storage disorders.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 27-Sep-2001 | $215M | 0000 | 00000 | Completed | Generating Revenue |
2. Early Stage VC (Series B) | 18-Apr-2001 | 0000 | 0000 | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 19-Sep-2000 | $8M | $8M | Completed | Product Development |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Aisling Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Catalyst Health Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
HealthCare Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Morgan Stanley Expansion Capital | Growth/Expansion | Majority | 000 0000 | 000000 0 | |
Strattech Partners | Venture Capital | Minority | 000 0000 | 000000 0 |